|
Adenoviral vector of serotype 5 modified to contain a chimeric sequence consisting of a minimal urokinase-type plasminogen activator receptor promoter preceded by three Notch-responsive elements, and coated with oligopeptide end-modified poly (beta-amino) esters |
|---|---|
| Trade Name | |
| Orphan Indication | Pancreatic Cancer |
| EU Market Approval | EU |
| EU Designation Date | 2017-10-16 00:00:00 |
| Sponsor | Sagetis Biotech, S.L. |
